Glaxosmithkline Recent News
Investment Fund Manager: GlaxoSmithKline Should Be Broken Up, Shares Tick Higher
Barron's Recap: Barnes & Noble, DSW Could Skyrocket
GlaxoSmithKline's 'Unexpected Disappointment'
Markets Reverse Early Morning Losses; Still Lower On The Day
Stifel Downgrades InterMune; Roche Offer 'Appropriate Ending'
Markets Little Changed Ahead Of The Federal Reserve's Policy Decision
Markets Sell-Off After Malaysian Airline Crash In Ukraine
Market Wrap For April 22: S&P Rises For Sixth Straight Day, Dow & Nasdaq Also Positive
Market Wrap For April 2: Markets On Four-Day Winning Streak
Market Wrap For March 20: Investors Showing No Post-Fed Decision Hangover
Market Wrap For March 10: Markets Slightly Lower On Chinese Growth Concerns
The Top Five Dow Stocks In February
GlaxoSmithKline, Kinder Morgan And Others Insiders Have Been Buying
Market Wrap For Febuary 20: S&P 500 Inches Closer To New Highs
Market Wrap For February 3: Bears In Complete and Absolute Control
Rising Short Interest In Pharmacyclics, Other Biotechs (AMGN, GILD, PCYC)
Gilead Sciences Leads In Rising Short Interest Among Biotechs
Apple, Wal-Mart And Other Companies With Monster Share Buyback (AAPL, WMT)
Short Interest Rises in Gilead Sciences, Onyx Pharmaceuticals (BIIB, GILD, ONXX)
Short Sellers Dump Amgen, Focus on Celgene, Gilead Sciences
Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)
Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)
Three More Defensive Stock Picks for 2013 (LLY, PFE, VTR)